Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (4) , 680-685
- https://doi.org/10.1161/01.atv.0000013287.08141.74
Abstract
We investigated in vivo the effect of cholesterol diet–induced hypercholesterolemia (HC) on thromboembolism in nonatherosclerotic rabbit mesenteric arterioles and venules (diameter 21 to 45 μm). After mechanical vessel wall injury, the ensuing thromboembolic reaction was studied by intravital videomicroscopy. A dramatic prolongation of embolization duration (median >600 seconds) was observed in the arterioles of the HC group compared with the arterioles of a normal chow–fed (NC) control group (142 seconds, P P <0.05). By contrast, in venules, cholesterol did not affect embolization duration (42 seconds for HC group, 34 seconds for NC group) and thrombus height (66% for HC group, 64% for NC group). Furthermore, the role of endothelial NO synthesis was studied. In arterioles, stimulation of endogenous NO synthesis through mesenteric superfusion of l -arginine (1 mmol/L) completely reversed cholesterol-enhanced embolization (152 seconds) but did not influence thrombus height (63%). l -Arginine had no effect in venules of the HC group (51 seconds) and nor in the arterioles and venules of the NC group (177 seconds for arterioles, 43 seconds for venules). This study indicates that hypercholesterolemia selectively enhances thrombus formation and embolization in arterioles but not in venules and that stimulation of endogenous NO production antagonizes this enhancement of arteriolar thromboembolism.Keywords
This publication has 18 references indexed in Scilit:
- Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthaseJournal of Clinical Investigation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Chronic dietary supplementation with ?-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivoCardiovascular Research, 1998
- Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic HumansJournal of the American College of Cardiology, 1997
- The formation of nitric oxide donors from peroxynitriteBritish Journal of Pharmacology, 1995
- Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1,834 men and women aged ≥ 62 yearsThe American Journal of Cardiology, 1994
- Oral Naftidrofuryl Prevents Platelet Hyperreactivity Ex Vivo and Inhibits Functional Desensitization to Prostacyclin in Hypercholesterolemic RabbitsJournal of Cardiovascular Pharmacology, 1993
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.Journal of Clinical Investigation, 1992
- Effect of blood gases and pH on thromboembolic reactions in rabbit mesenteric microvesselsPflügers Archiv - European Journal of Physiology, 1989
- Increased platelet aggregability is associated with increased protacyclin production by vessel walls in hypercholesterolemic rabbitsProstaglandins, 1982